Abou-Mourad, Y.R., Lau, B.C., Barnett, M.J., et al. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplant. 45:2 (2010), 295–302, 10.1038/bmt.2009.128.
Armstrong, D., Hawkins, E., Rouah, E., et al. Graft-vs-host disease in the central nervous system. Am. J. Clin. Pathol., 107(3), 1997, 379.
Belle, L., Zhou, V., Stuhr, K.L., Beatka, M., Siebers, E.M., Knight, J.M., Drobyski, W.R., Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD. JCI Insight, 2(14), 2017, 10.1172/jci.insight.93726.
Bhatia, S., Francisco, L., Carter, A., et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110:10 (2007), 3784–3792, 10.1182/blood-2007-03-082933.
Brownback, K.R., Thomas, L.A., McGuirk, J.P., Ganguly, S., Streiler, C., Abhyankar, S., Effect of rituximab on pulmonary function in bronchiolitis obliterans syndrome due to graft-versus-host-disease. Lung 195:6 (2017), 781–788, 10.1007/s00408-017-0051-0.
Campbell, J.N., Morris, P.P., Cerebral vasculitis in graft-versus host disease: a case report. Am. J. Neuroradiol. 26:3 (2005), 654–656.
Celliers, L., Hung, T., Al-Ogaili, Z., Moschilla, G., Knezevic, W., Voltage-gated potassium channel antibody limbic encephalitis: a case illustrating the neuropsychiatric and PET/CT features with clinical and imaging follow-up. Austr. Psychiatry 24:6 (2016), 538–540, 10.1177/1039856216663734.
Copelan, E.A., Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354:17 (2006), 1813–1826, 10.1056/NEJMra052638.
Delios, A.M., Rosenblum, M., Jakubowski, A.A., et al. Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hematopoietic stem cell transplantation for hematologic disease. J. Neuro. Oncol. 110:2 (2012), 251–256, 10.1007/s11060-012-0962-9.
Dong, A., Gao, M., Wang, Y., Gao, L., Zuo, C., Interesting image FDG PET / CT in acute tumefactive multiple sclerosis occurring in a case of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Clin. Nucl. Med. 41:9 (2016), e414–e416, 10.1097/RLU.0000000000001193.
Gratwohl, A., Baldomero, H., Aljurf, M., Pasquini, M.C., Bouzas, L.F., Yoshimi, A., et al. Hematopoietic stem cell transplantation: a 360 globales perspectives. JAMA 303:16 (2010), 1617–1624 25 https://doi.org/10.1001/jama.2010.491.
Grauer, O., Wolff, D., Bertz, H., et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease. Brain 133:10 (2010), 2852–2865, 10.1093/brain/awq245.
Grauss, Francesc, Titulaer, Maarten J., Balu, Ramani, Benseler, Susanne, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15 (2016), 391–404, 10.1016/ S1474-4422(15)00401-9.
Hartrampf, S., Dudakov, J.A., Johnson, L.K., Smith, O.M., Tsai, J., Singer, N., et al. The central nervous system is a target of acute graft versus host disease in mice. Blood 121:10 (2013), 1906–1910, 10.1182/blood-2012-09-456590.
Harvey, C.M., Gottipati, R., Schwarz, S., et al. Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHD. Bone Marrow Transplant. 49:6 (2014), 854–856, 10.1038/bmt.2014.29.
Iwasaki, Y., Sako, K., Ohara, Y., et al. Subacute panencephalitis associated with chronic graft-versus-host disease. Acta Neuropathol. 85:5 (1993), 566–572, 10.1007/BF00230498.
Jagasia, M.H., Greinix, H.T., Arora, M., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol. Blood Marrow Transpl. 21:3 (2015), 389–401, 10.1016/j.bbmt.2014.12.001.
Kamble, R.T., Chang, C.C., Sanchez, S., et al. Central nervous system graft versus-host disease: report of two cases and literature review. Bone Marrow Transplant. 39:1 (2007), 49–52, 10.1038/sj.bmt.1705540.
Lagarde, S., Guedj, E., Interest of cerebral positron emission tomography (PET) in dysimmune encephalitis. Med. Nucl. 39:3 (2015), 279–282, 10.1016/j.mednuc.2015.03.002.
MacDonald, K.P.A., Hill, G.R., Blazar, B.R., Chronic graft-versus-host disease: biological insights from preclinical and clinical studies. Blood 129:1 (2017), 13–21, 10.1182/blood-2016-06-686618.
Maffini, E., Festuccia, M., Brunello, L., Boccadoro, M., Giaccone, L., Bruno, B., Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 23:3 (2017), 388–397, 10.1016/j.bbmt.2016.12.632.
Majhail, N.S., Farnia, S.H., Carpenter, P.A., Champlin, R.E., Crawford, S., Marks, D.I., Palmer, J., Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant. 21:11 (2015), 1863–1869, 10.1016/j.bbmt.2015.07.032.
Marosi, C., Budka, H., Grimm, G., et al. Fatal encephalitis in a patient with chronic graft-versus-host disease. Bone Marrow Transplant. 6:1 (1990), 53–57.
Morbelli, S., Arbizu, J., Booij, J., Chen, M.K., Chetelat, G., Cross, D.J., Barthel, H., The need of standardization and of large clinical studies in an emerging indication of [18F] FDG PET: the autoimmune encephalitis. Eur. J. Nucl. Med. Mol. Imaging 44:3 (2017), 353–357, 10.1007/s00259-016-3598-8.
Openshaw, H., Neurological Manifestations of Chronic Graft Versus Host Disease. Chronic Graft versus Host Disease. 2009, Cambridge University Press, New York, 243–255.
Padovan, C.S., Bise, K., Hahn, J., et al. Angiitis of the central nervous system after allogeneic bone marrow transplantation?. Stroke J. Cereb. Circ. 30:8 (1999), 1651–1656, 10.1038/bmt.2009.323.
Pechey, V., Parratt, J., Vo, L., Stevenson, W., Successful treatment of meningeal graft-versus-host disease in a hematopoietic stem cell transplant recipient. Int. J. Hematol. 101:2 (2015), 203–206, 10.1007/s12185-014-1704-x.
Popławska-Domaszewicz K., Florczak-Wyspiańska J., Kozubski W. and Michalak S., 2018. Paraneoplastic movement disorders. Rev. Neurosci. 0(0), 1–11. : https://doi.org/10.1515/revneuro-2017-0081.
Rhoades, R., Gaballa, S., The role of B cell targeting in chronic graft-versus-host disease. Biomedicine, 5(4), 2017, E61, 10.3390/biomedicines5040061.
Rouah, E., Gruber, R., Shearer, W., et al. Graft-versus-host disease in the central nervous system: a real entity?. Am. J. Clin. Pathol. 89:4 (1988), 543–546.
Ruggiu, M., Cuccuini, W., Mokhtari, K., Meignin, V., Peffault De Latour, R., Robin, M., Michonneau, D., Case report: central nervous system involvement of human graft versus host disease. Medicine, 96(42), 2017, e8303, 10.1097/MD.0000000000008303.
Saad, A.G., Alyea, E.P., Wen, P.Y., et al. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation. J. Clin. Oncol. 27:30 (2009), e147–e149, 10.1200/JCO.2009.21.7919.
Schmitz, N., Eapen, M., Horowitz, M.M., et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108:13 (2006), 4288–4290, 10.1182/blood-2006-05-024042.
Solomon, S.R., Sizemore, C., Zhang, X., et al. Current GVHD-free, relapse-free survival – a dynamic endpoint to better define efficacy following allogenic transplant. Biol. Blood Marrow Transplt. 23:7 (2017), 1208–1214, 10.1016/j.bbmt.2017.02.022.
Sonderen, A., Van Ariño, H., Petit-Pedrol, M., Leypoldt, F., Körtvélyessy, P., Lancaster, E., Schreurs, M.W.J., The clinical spectrum of Caspr2 antibody – associated disease. Neurology 87:5 (2016), 521–528, 10.1212/WNL.0000000000002917.
Sostak, P., Reich, P., Padovan, C.S., Gerbitz, A., Holler, E., Straube, A., Cerebral endothelial expression of adhesion molecules in mice with chronic graft-versus-host disease. Stroke 35:5 (2004), 1158–1163, 10.1161/01.STR.0000125865.01546.bb.
Sostak, P., Padovan, C.S., Eigenbrod, S., Roeber, S., Segerer, S., Schankin, C., et al. Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplant. 45:7 (2010), 1181–1188, 10.1038/bmt.2009.323.
Stefanou, M.I., Bischof, F., Central and peripheral nervous system immune-mediated demyelinating disease after allogeneic hematopoietic stem cell transplantation. J. Neuroimmunol. 307 (2017), 74–81, 10.1016/j.jneuroim.2017.04.005.
Terada, M., Nakamagoe, K., Obara, N., Ogawa, S., Sakamoto, N., Sato, T., et al. Chronic graft-versus-host disease presenting with multiple punctate intracranial lesions on contrast-enhanced magnetic resonance imaging. Intern. Med. 56:3 (2017), 363–368, 10.2169/internalmedicine.56.7329.
Tomonari, A., Tojo, A., Adachi, D., et al. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia. Ann. Hematol. 82:1 (2003), 37–40, 10.1007/s00277-002-0573-1.
Voss, M., Bischof, F., Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases. BMC Neurol., 10, 2010, 76, 10.1186/1471-2377-10-76.
Wolff, D., Schleuning, M., Von Harsdorf, S., Bacher, U., Gerbitz, A., Stadler, M., Holler, E., Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol. Blood Marrow Transpl. 17:1 (2011), 1–17, 10.1016/j.bbmt.2010.05.011.